Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

October 28, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Atherosclerosis: Combating the Killer!

Genetic mutations could now be easily understood!!!

EF-TU: Travel back in time and evolve with this special protein!!!

Atherosclerosis: Combating the Killer!
  • BiotechToday
  • World

Atherosclerosis: Combating the Killer!

bioxone May 6, 2021May 6, 2021

Richismita Hazra, Amity University Kolkata

Heart disease is the leading cause of death all across the globe. It can undoubtedly be called as ‘World’s No.1 Killer’. One of the major and common causes of this killer disease is atherosclerosis. Atherosclerosis refers to the piling up of fats, cholesterol, and other substances in and on our artery walls. This assemblage is termed plaque and can cause our arteries to narrow thereby triggering blood clots. It can potentially occur in every artery of our body and cause disability or death.

According to the researchers at the University Of Virginia School Of Medicine, strengthening the fibrous caps overlying atherosclerotic plaque could be a promising way to ward off heart attacks and strokes. These fibrous caps play the role of protective shields that act like patches on a tire. It prevents the plaque from rupturing which ultimately would prevent a heart attack or a stroke. Redefining the understanding of how the protective caps form and how they attain their stability has been revealed by the scientists. This may be of immense help to doctors who could use these insights to prevent plaques from rupturing.

It was assumed in the past that most of the protective fibrous cap cells originated from smooth muscles. However, advanced research highlights the dynamic nature of this structure. Recent research suggests that up to 40% of the fibrous cells in the cap (in lab mice) are not of smooth muscle cell origin. In human lesions, approximately 20% – 25% of the fibrous cap cells do not originate from smooth muscle cells. Other sources include endothelial cells and immune cells.

This study unveils a potentially novel approach towards shrinking the probability of plaque rupture. The research team urges scientists and pharmaceutical companies to re-examine their proposition in preventing the killer disease.

Also read:Genetic mutations could now be easily understood!!!

Source: Newman, A.A.C., et al. (2021) Multiple cell types contribute to the atherosclerotic lesion fibrous cap by PDGFRβ and bioenergetic mechanisms. Nature Metabolism. doi.org/10.1038/s42255-020-00338-8.

  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged arteries atherosclerosis blood flow cells cholesterol death dynamic fats fibrous cap heart heart attack heart disease lesions muscle cells plaques rupture smooth muscle cells stroke treatment

One thought on “Atherosclerosis: Combating the Killer!”

  1. Pingback: EF-TU: Travel back in time and evolve with this special protein!!! - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • India

EF-TU: Travel back in time and evolve with this special protein!!!

bioxone May 7, 2021

Anannya Roy, Amity University Kolkata One of the main functions a cell performs is the synthesis of proteins. This is done with the help of a set of factors called “transcription factors”. A team of researchers from Uppasala University have succeeded in studying transcription factors that are several billion years old. The studies helped them […]

EF-TU

Related Post

  • BiotechToday
  • World

Sea corals – A new way to combat heat stress

BioTech Today August 19, 2021August 19, 2021

Agrima Bhatt, Rajasthan University The environment has already been affected by global climate change. Glaciers have receded, ice on rivers and lakes has broken up earlier, plant and animal ranges have altered, and trees have begun to bloom earlier. Scientists are confident that global temperatures will continue to climb for decades to come, owing to […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • India

COVID UPDATE: Decrease in daily active cases in India

bioxone October 13, 2020October 13, 2020

Camelia Bhattacharyya, Amity University Kolkata The coronavirus, or the virus which has resulted in the whole world to shutdown, the ecosystem to change and us to depend completely on technology (to manage the economic conditions) and their immunity (since its more or less the survival of the fittest) first started its game in Wuhan, China. […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

COVID herd immunity is probably not possible

bioxone March 29, 2021March 29, 2021

Rohit Bhattacharjee, Amity University, Kolkata The key to herd immunity is that, whether or not an individual becomes infected, there are too few susceptible hosts around to keep up transmission — individuals who are immunized or have effectively had the disease can’t spread the infection. The vaccines created by Moderna and Pfizer–BioNTech, for instance, are […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy